NovaBiotics Ltd Company Profile

10:00 EDT 22nd March 2018 | BioPortfolio

NovaBiotics Ltd is a clinical-stage speciality biotechnology company focused on the application of first-in-class anti-infective technology for difficult-to-treat, medically unmet fungal and bacterial conditions.

As a leading innovator in the anti-infectives space, Novabiotics' business model is to develop candidate therapeutics to early/mid clinical proof of concept prior to further development of our product candidates and technology platform with commercialisation, out-licensing or co-development partners thereafter.

Using informed, rational drug design principles versus high-risk screening strategies, the company has streamlined this process such that we have delivered products to clinic in less than 5 years from patent priority dates.

Founded in Aberdeen by Dr. Deborah O'Neil in 2004, NovaBiotics Board of Directors provides a wealth of expertise in the biotechnology and pharmaceutical sector and the science team now in place (comprising immunology, microbiology and antimicrobial peptide expertise) provides a wealth of technological know-how and skills including proven, sector-specific expertise in anti-infective business development.

Over-use of antibiotics and antifungals and consequent drug resistance leaves the application and success of current antimicrobial therapies ever more limited. Global healthcare is facing an unprecedented crisis with the current and predicted future unmet clinical need for effective, safe and resistance-free therapies to combat bacterial, fungal, viral and other infectious diseases and conditions. Chemistry-led approaches have failed to solve this problem and so NovaBiotics has employed a very different approach, informed or rational drug design, with nature as the template for a totally novel class of antimicrobial therapies that have the potential to meet the need for safer, more effective antifungal and antibacterial treatments.

NovaBiotics' proprietary technology comprises peptides; biologic molecules that in nature form the cornerstone of the body's first line of defence against the spectrum of potentially harmful microbes (bacteria, fungi, viruses, protozoa) with which we come into contact daily. NovaBiotics has capitalised on the benefical properties of these natural infection-fighting agents and has engineered third-generation derivatives that can be applied for the treatment and even prevention of a range of fungal and bacterial infections.

Importantly, the mode of action of NovaBiotics' compounds is such that they kill rather than merely inhibit pathogens and the likelihood of acquired or transmitted pathogen resistance developing in micro-organisms which have been exposed to the peptides is highly unlikely, if not impossible.


Cruickshank Building
AB21 9TR
United Kingdom


Phone: +44 (0)1224 711377
Fax: +44 (0)1224 711370

News Articles [1 Associated News Articles listed on BioPortfolio]

Novabiotics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryNovabiotics Ltd Novabiotics is a biotechnology company that designs and develops antiinfectives for treating diseases with unmet medical needs. The company employs its proprietary antiinfective...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]

NovaBiotics Ltd

NovaBiotics Ltd is a clinical-stage speciality biotechnology company focused on the application of first-in-class anti-infective technology for difficult-to-treat, medically unmet fungal and bacteri...

More Information about "NovaBiotics Ltd" on BioPortfolio

We have published hundreds of NovaBiotics Ltd news stories on BioPortfolio along with dozens of NovaBiotics Ltd Clinical Trials and PubMed Articles about NovaBiotics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovaBiotics Ltd Companies in our database. You can also find out about relevant NovaBiotics Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record